English
简体中文
Total: £ 56.28
Published Date: 2025-02-20 | Pages: 103 | Tables: 110 | Medical Care
The global market for Antibody Development and Production Service was valued at US$ 2225 million in the year 2024 and is projected to reach a revised size of US$ 3691 million by 2031, growing at a CAGR of 7.5% during the forecast period.
Antibody development and production service is a broader service that covers the development, optimization, and production of monoclonal and polyclonal antibodies. This service typically includes antigen design and preparation, antibody screening and optimization (such as affinity maturation, Fc modification, etc.), antibody expression and purification, as well as antibody functional validation (such as ELISA, Western blot, flow cytometry, etc.). Suitable for antibody needs in different fields such as scientific research, diagnosis, and treatment.
North American market for Antibody Development and Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Antibody Development and Production Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Antibody Development and Production Service in Medical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Antibody Development and Production Service include ThermoFisher, Abcam, BICO, Rockland, ProSci, Biocompare, Bio-Rad, Evitria AG, Capra Science, Innovagen, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antibody Development and Production Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Development and Production Service.
The Antibody Development and Production Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antibody Development and Production Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Development and Production Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ThermoFisher
Abcam
BICO
Rockland
ProSci
Biocompare
Bio-Rad
Evitria AG
Capra Science
Innovagen
Life Science Group
Randox
Davids Biotechnologie
Abgent
InVivo BioTech Services
BioGenes
Helmholtz Zentrum München
Kaneka Eurogentec
Beijing Abace Biology
Beijing Sino Biological
Nanjing GenScript Biotechnology
Shanghai Sangon Biotech
Nanjing Zoonbio Biotechnology
Suzhou Synbio Technologies
Segment by Type
Monoclonal Antibodies
Polyclonal Antibodies
Segment by Application
Medical
Pharmaceutical
Scientific Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Development and Production Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Development and Production Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibodies
1.3 Market by Application
1.3.1 Global Antibody Development and Production Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical
1.3.3 Pharmaceutical
1.3.4 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Development and Production Service Market Perspective (2020-2031)
2.2 Global Antibody Development and Production Service Growth Trends by Region
2.2.1 Global Antibody Development and Production Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antibody Development and Production Service Historic Market Size by Region (2020-2025)
2.2.3 Antibody Development and Production Service Forecasted Market Size by Region (2026-2031)
2.3 Antibody Development and Production Service Market Dynamics
2.3.1 Antibody Development and Production Service Industry Trends
2.3.2 Antibody Development and Production Service Market Drivers
2.3.3 Antibody Development and Production Service Market Challenges
2.3.4 Antibody Development and Production Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Development and Production Service Players by Revenue
3.1.1 Global Top Antibody Development and Production Service Players by Revenue (2020-2025)
3.1.2 Global Antibody Development and Production Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Antibody Development and Production Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antibody Development and Production Service Revenue
3.4 Global Antibody Development and Production Service Market Concentration Ratio
3.4.1 Global Antibody Development and Production Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Development and Production Service Revenue in 2024
3.5 Global Key Players of Antibody Development and Production Service Head office and Area Served
3.6 Global Key Players of Antibody Development and Production Service, Product and Application
3.7 Global Key Players of Antibody Development and Production Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Development and Production Service Breakdown Data by Type
4.1 Global Antibody Development and Production Service Historic Market Size by Type (2020-2025)
4.2 Global Antibody Development and Production Service Forecasted Market Size by Type (2026-2031)
5 Antibody Development and Production Service Breakdown Data by Application
5.1 Global Antibody Development and Production Service Historic Market Size by Application (2020-2025)
5.2 Global Antibody Development and Production Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antibody Development and Production Service Market Size (2020-2031)
6.2 North America Antibody Development and Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antibody Development and Production Service Market Size by Country (2020-2025)
6.4 North America Antibody Development and Production Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Development and Production Service Market Size (2020-2031)
7.2 Europe Antibody Development and Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antibody Development and Production Service Market Size by Country (2020-2025)
7.4 Europe Antibody Development and Production Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Development and Production Service Market Size (2020-2031)
8.2 Asia-Pacific Antibody Development and Production Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antibody Development and Production Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Antibody Development and Production Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Development and Production Service Market Size (2020-2031)
9.2 Latin America Antibody Development and Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antibody Development and Production Service Market Size by Country (2020-2025)
9.4 Latin America Antibody Development and Production Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Development and Production Service Market Size (2020-2031)
10.2 Middle East & Africa Antibody Development and Production Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antibody Development and Production Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Antibody Development and Production Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ThermoFisher
11.1.1 ThermoFisher Company Details
11.1.2 ThermoFisher Business Overview
11.1.3 ThermoFisher Antibody Development and Production Service Introduction
11.1.4 ThermoFisher Revenue in Antibody Development and Production Service Business (2020-2025)
11.1.5 ThermoFisher Recent Development
11.2 Abcam
11.2.1 Abcam Company Details
11.2.2 Abcam Business Overview
11.2.3 Abcam Antibody Development and Production Service Introduction
11.2.4 Abcam Revenue in Antibody Development and Production Service Business (2020-2025)
11.2.5 Abcam Recent Development
11.3 BICO
11.3.1 BICO Company Details
11.3.2 BICO Business Overview
11.3.3 BICO Antibody Development and Production Service Introduction
11.3.4 BICO Revenue in Antibody Development and Production Service Business (2020-2025)
11.3.5 BICO Recent Development
11.4 Rockland
11.4.1 Rockland Company Details
11.4.2 Rockland Business Overview
11.4.3 Rockland Antibody Development and Production Service Introduction
11.4.4 Rockland Revenue in Antibody Development and Production Service Business (2020-2025)
11.4.5 Rockland Recent Development
11.5 ProSci
11.5.1 ProSci Company Details
11.5.2 ProSci Business Overview
11.5.3 ProSci Antibody Development and Production Service Introduction
11.5.4 ProSci Revenue in Antibody Development and Production Service Business (2020-2025)
11.5.5 ProSci Recent Development
11.6 Biocompare
11.6.1 Biocompare Company Details
11.6.2 Biocompare Business Overview
11.6.3 Biocompare Antibody Development and Production Service Introduction
11.6.4 Biocompare Revenue in Antibody Development and Production Service Business (2020-2025)
11.6.5 Biocompare Recent Development
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Antibody Development and Production Service Introduction
11.7.4 Bio-Rad Revenue in Antibody Development and Production Service Business (2020-2025)
11.7.5 Bio-Rad Recent Development
11.8 Evitria AG
11.8.1 Evitria AG Company Details
11.8.2 Evitria AG Business Overview
11.8.3 Evitria AG Antibody Development and Production Service Introduction
11.8.4 Evitria AG Revenue in Antibody Development and Production Service Business (2020-2025)
11.8.5 Evitria AG Recent Development
11.9 Capra Science
11.9.1 Capra Science Company Details
11.9.2 Capra Science Business Overview
11.9.3 Capra Science Antibody Development and Production Service Introduction
11.9.4 Capra Science Revenue in Antibody Development and Production Service Business (2020-2025)
11.9.5 Capra Science Recent Development
11.10 Innovagen
11.10.1 Innovagen Company Details
11.10.2 Innovagen Business Overview
11.10.3 Innovagen Antibody Development and Production Service Introduction
11.10.4 Innovagen Revenue in Antibody Development and Production Service Business (2020-2025)
11.10.5 Innovagen Recent Development
11.11 Life Science Group
11.11.1 Life Science Group Company Details
11.11.2 Life Science Group Business Overview
11.11.3 Life Science Group Antibody Development and Production Service Introduction
11.11.4 Life Science Group Revenue in Antibody Development and Production Service Business (2020-2025)
11.11.5 Life Science Group Recent Development
11.12 Randox
11.12.1 Randox Company Details
11.12.2 Randox Business Overview
11.12.3 Randox Antibody Development and Production Service Introduction
11.12.4 Randox Revenue in Antibody Development and Production Service Business (2020-2025)
11.12.5 Randox Recent Development
11.13 Davids Biotechnologie
11.13.1 Davids Biotechnologie Company Details
11.13.2 Davids Biotechnologie Business Overview
11.13.3 Davids Biotechnologie Antibody Development and Production Service Introduction
11.13.4 Davids Biotechnologie Revenue in Antibody Development and Production Service Business (2020-2025)
11.13.5 Davids Biotechnologie Recent Development
11.14 Abgent
11.14.1 Abgent Company Details
11.14.2 Abgent Business Overview
11.14.3 Abgent Antibody Development and Production Service Introduction
11.14.4 Abgent Revenue in Antibody Development and Production Service Business (2020-2025)
11.14.5 Abgent Recent Development
11.15 InVivo BioTech Services
11.15.1 InVivo BioTech Services Company Details
11.15.2 InVivo BioTech Services Business Overview
11.15.3 InVivo BioTech Services Antibody Development and Production Service Introduction
11.15.4 InVivo BioTech Services Revenue in Antibody Development and Production Service Business (2020-2025)
11.15.5 InVivo BioTech Services Recent Development
11.16 BioGenes
11.16.1 BioGenes Company Details
11.16.2 BioGenes Business Overview
11.16.3 BioGenes Antibody Development and Production Service Introduction
11.16.4 BioGenes Revenue in Antibody Development and Production Service Business (2020-2025)
11.16.5 BioGenes Recent Development
11.17 Helmholtz Zentrum München
11.17.1 Helmholtz Zentrum München Company Details
11.17.2 Helmholtz Zentrum München Business Overview
11.17.3 Helmholtz Zentrum München Antibody Development and Production Service Introduction
11.17.4 Helmholtz Zentrum München Revenue in Antibody Development and Production Service Business (2020-2025)
11.17.5 Helmholtz Zentrum München Recent Development
11.18 Kaneka Eurogentec
11.18.1 Kaneka Eurogentec Company Details
11.18.2 Kaneka Eurogentec Business Overview
11.18.3 Kaneka Eurogentec Antibody Development and Production Service Introduction
11.18.4 Kaneka Eurogentec Revenue in Antibody Development and Production Service Business (2020-2025)
11.18.5 Kaneka Eurogentec Recent Development
11.19 Beijing Abace Biology
11.19.1 Beijing Abace Biology Company Details
11.19.2 Beijing Abace Biology Business Overview
11.19.3 Beijing Abace Biology Antibody Development and Production Service Introduction
11.19.4 Beijing Abace Biology Revenue in Antibody Development and Production Service Business (2020-2025)
11.19.5 Beijing Abace Biology Recent Development
11.20 Beijing Sino Biological
11.20.1 Beijing Sino Biological Company Details
11.20.2 Beijing Sino Biological Business Overview
11.20.3 Beijing Sino Biological Antibody Development and Production Service Introduction
11.20.4 Beijing Sino Biological Revenue in Antibody Development and Production Service Business (2020-2025)
11.20.5 Beijing Sino Biological Recent Development
11.21 Nanjing GenScript Biotechnology
11.21.1 Nanjing GenScript Biotechnology Company Details
11.21.2 Nanjing GenScript Biotechnology Business Overview
11.21.3 Nanjing GenScript Biotechnology Antibody Development and Production Service Introduction
11.21.4 Nanjing GenScript Biotechnology Revenue in Antibody Development and Production Service Business (2020-2025)
11.21.5 Nanjing GenScript Biotechnology Recent Development
11.22 Shanghai Sangon Biotech
11.22.1 Shanghai Sangon Biotech Company Details
11.22.2 Shanghai Sangon Biotech Business Overview
11.22.3 Shanghai Sangon Biotech Antibody Development and Production Service Introduction
11.22.4 Shanghai Sangon Biotech Revenue in Antibody Development and Production Service Business (2020-2025)
11.22.5 Shanghai Sangon Biotech Recent Development
11.23 Nanjing Zoonbio Biotechnology
11.23.1 Nanjing Zoonbio Biotechnology Company Details
11.23.2 Nanjing Zoonbio Biotechnology Business Overview
11.23.3 Nanjing Zoonbio Biotechnology Antibody Development and Production Service Introduction
11.23.4 Nanjing Zoonbio Biotechnology Revenue in Antibody Development and Production Service Business (2020-2025)
11.23.5 Nanjing Zoonbio Biotechnology Recent Development
11.24 Suzhou Synbio Technologies
11.24.1 Suzhou Synbio Technologies Company Details
11.24.2 Suzhou Synbio Technologies Business Overview
11.24.3 Suzhou Synbio Technologies Antibody Development and Production Service Introduction
11.24.4 Suzhou Synbio Technologies Revenue in Antibody Development and Production Service Business (2020-2025)
11.24.5 Suzhou Synbio Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antibody Development and Production Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Polyclonal Antibodies
Table 4. Global Antibody Development and Production Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Antibody Development and Production Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Antibody Development and Production Service Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Antibody Development and Production Service Market Share by Region (2020-2025)
Table 8. Global Antibody Development and Production Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Antibody Development and Production Service Market Share by Region (2026-2031)
Table 10. Antibody Development and Production Service Market Trends
Table 11. Antibody Development and Production Service Market Drivers
Table 12. Antibody Development and Production Service Market Challenges
Table 13. Antibody Development and Production Service Market Restraints
Table 14. Global Antibody Development and Production Service Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Antibody Development and Production Service Market Share by Players (2020-2025)
Table 16. Global Top Antibody Development and Production Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Development and Production Service as of 2024)
Table 17. Ranking of Global Top Antibody Development and Production Service Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Antibody Development and Production Service Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Antibody Development and Production Service, Headquarters and Area Served
Table 20. Global Key Players of Antibody Development and Production Service, Product and Application
Table 21. Global Key Players of Antibody Development and Production Service, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibody Development and Production Service Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Antibody Development and Production Service Revenue Market Share by Type (2020-2025)
Table 25. Global Antibody Development and Production Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Antibody Development and Production Service Revenue Market Share by Type (2026-2031)
Table 27. Global Antibody Development and Production Service Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Antibody Development and Production Service Revenue Market Share by Application (2020-2025)
Table 29. Global Antibody Development and Production Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Antibody Development and Production Service Revenue Market Share by Application (2026-2031)
Table 31. North America Antibody Development and Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Antibody Development and Production Service Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Antibody Development and Production Service Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Antibody Development and Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Antibody Development and Production Service Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Antibody Development and Production Service Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Antibody Development and Production Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Antibody Development and Production Service Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Antibody Development and Production Service Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Antibody Development and Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Antibody Development and Production Service Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Antibody Development and Production Service Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Antibody Development and Production Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Antibody Development and Production Service Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Antibody Development and Production Service Market Size by Country (2026-2031) & (US$ Million)
Table 46. ThermoFisher Company Details
Table 47. ThermoFisher Business Overview
Table 48. ThermoFisher Antibody Development and Production Service Product
Table 49. ThermoFisher Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 50. ThermoFisher Recent Development
Table 51. Abcam Company Details
Table 52. Abcam Business Overview
Table 53. Abcam Antibody Development and Production Service Product
Table 54. Abcam Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 55. Abcam Recent Development
Table 56. BICO Company Details
Table 57. BICO Business Overview
Table 58. BICO Antibody Development and Production Service Product
Table 59. BICO Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 60. BICO Recent Development
Table 61. Rockland Company Details
Table 62. Rockland Business Overview
Table 63. Rockland Antibody Development and Production Service Product
Table 64. Rockland Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 65. Rockland Recent Development
Table 66. ProSci Company Details
Table 67. ProSci Business Overview
Table 68. ProSci Antibody Development and Production Service Product
Table 69. ProSci Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 70. ProSci Recent Development
Table 71. Biocompare Company Details
Table 72. Biocompare Business Overview
Table 73. Biocompare Antibody Development and Production Service Product
Table 74. Biocompare Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 75. Biocompare Recent Development
Table 76. Bio-Rad Company Details
Table 77. Bio-Rad Business Overview
Table 78. Bio-Rad Antibody Development and Production Service Product
Table 79. Bio-Rad Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 80. Bio-Rad Recent Development
Table 81. Evitria AG Company Details
Table 82. Evitria AG Business Overview
Table 83. Evitria AG Antibody Development and Production Service Product
Table 84. Evitria AG Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 85. Evitria AG Recent Development
Table 86. Capra Science Company Details
Table 87. Capra Science Business Overview
Table 88. Capra Science Antibody Development and Production Service Product
Table 89. Capra Science Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 90. Capra Science Recent Development
Table 91. Innovagen Company Details
Table 92. Innovagen Business Overview
Table 93. Innovagen Antibody Development and Production Service Product
Table 94. Innovagen Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 95. Innovagen Recent Development
Table 96. Life Science Group Company Details
Table 97. Life Science Group Business Overview
Table 98. Life Science Group Antibody Development and Production Service Product
Table 99. Life Science Group Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 100. Life Science Group Recent Development
Table 101. Randox Company Details
Table 102. Randox Business Overview
Table 103. Randox Antibody Development and Production Service Product
Table 104. Randox Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 105. Randox Recent Development
Table 106. Davids Biotechnologie Company Details
Table 107. Davids Biotechnologie Business Overview
Table 108. Davids Biotechnologie Antibody Development and Production Service Product
Table 109. Davids Biotechnologie Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 110. Davids Biotechnologie Recent Development
Table 111. Abgent Company Details
Table 112. Abgent Business Overview
Table 113. Abgent Antibody Development and Production Service Product
Table 114. Abgent Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 115. Abgent Recent Development
Table 116. InVivo BioTech Services Company Details
Table 117. InVivo BioTech Services Business Overview
Table 118. InVivo BioTech Services Antibody Development and Production Service Product
Table 119. InVivo BioTech Services Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 120. InVivo BioTech Services Recent Development
Table 121. BioGenes Company Details
Table 122. BioGenes Business Overview
Table 123. BioGenes Antibody Development and Production Service Product
Table 124. BioGenes Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 125. BioGenes Recent Development
Table 126. Helmholtz Zentrum München Company Details
Table 127. Helmholtz Zentrum München Business Overview
Table 128. Helmholtz Zentrum München Antibody Development and Production Service Product
Table 129. Helmholtz Zentrum München Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 130. Helmholtz Zentrum München Recent Development
Table 131. Kaneka Eurogentec Company Details
Table 132. Kaneka Eurogentec Business Overview
Table 133. Kaneka Eurogentec Antibody Development and Production Service Product
Table 134. Kaneka Eurogentec Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 135. Kaneka Eurogentec Recent Development
Table 136. Beijing Abace Biology Company Details
Table 137. Beijing Abace Biology Business Overview
Table 138. Beijing Abace Biology Antibody Development and Production Service Product
Table 139. Beijing Abace Biology Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 140. Beijing Abace Biology Recent Development
Table 141. Beijing Sino Biological Company Details
Table 142. Beijing Sino Biological Business Overview
Table 143. Beijing Sino Biological Antibody Development and Production Service Product
Table 144. Beijing Sino Biological Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 145. Beijing Sino Biological Recent Development
Table 146. Nanjing GenScript Biotechnology Company Details
Table 147. Nanjing GenScript Biotechnology Business Overview
Table 148. Nanjing GenScript Biotechnology Antibody Development and Production Service Product
Table 149. Nanjing GenScript Biotechnology Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 150. Nanjing GenScript Biotechnology Recent Development
Table 151. Shanghai Sangon Biotech Company Details
Table 152. Shanghai Sangon Biotech Business Overview
Table 153. Shanghai Sangon Biotech Antibody Development and Production Service Product
Table 154. Shanghai Sangon Biotech Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 155. Shanghai Sangon Biotech Recent Development
Table 156. Nanjing Zoonbio Biotechnology Company Details
Table 157. Nanjing Zoonbio Biotechnology Business Overview
Table 158. Nanjing Zoonbio Biotechnology Antibody Development and Production Service Product
Table 159. Nanjing Zoonbio Biotechnology Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 160. Nanjing Zoonbio Biotechnology Recent Development
Table 161. Suzhou Synbio Technologies Company Details
Table 162. Suzhou Synbio Technologies Business Overview
Table 163. Suzhou Synbio Technologies Antibody Development and Production Service Product
Table 164. Suzhou Synbio Technologies Revenue in Antibody Development and Production Service Business (2020-2025) & (US$ Million)
Table 165. Suzhou Synbio Technologies Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
Table 169. Authors List of This Report
List of Figures
Figure 1. Antibody Development and Production Service Picture
Figure 2. Global Antibody Development and Production Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antibody Development and Production Service Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibodies Features
Figure 5. Polyclonal Antibodies Features
Figure 6. Global Antibody Development and Production Service Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Antibody Development and Production Service Market Share by Application: 2024 VS 2031
Figure 8. Medical Case Studies
Figure 9. Pharmaceutical Case Studies
Figure 10. Scientific Research Case Studies
Figure 11. Antibody Development and Production Service Report Years Considered
Figure 12. Global Antibody Development and Production Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Antibody Development and Production Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Antibody Development and Production Service Market Share by Region: 2024 VS 2031
Figure 15. Global Antibody Development and Production Service Market Share by Players in 2024
Figure 16. Global Antibody Development and Production Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Antibody Development and Production Service Revenue in 2024
Figure 18. North America Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Antibody Development and Production Service Market Share by Country (2020-2031)
Figure 20. United States Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Antibody Development and Production Service Market Share by Country (2020-2031)
Figure 24. Germany Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Antibody Development and Production Service Market Share by Region (2020-2031)
Figure 32. China Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Antibody Development and Production Service Market Share by Country (2020-2031)
Figure 40. Mexico Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Antibody Development and Production Service Market Share by Country (2020-2031)
Figure 44. Turkey Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Antibody Development and Production Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. ThermoFisher Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 48. Abcam Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 49. BICO Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 50. Rockland Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 51. ProSci Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 52. Biocompare Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 53. Bio-Rad Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 54. Evitria AG Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 55. Capra Science Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 56. Innovagen Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 57. Life Science Group Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 58. Randox Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 59. Davids Biotechnologie Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 60. Abgent Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 61. InVivo BioTech Services Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 62. BioGenes Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 63. Helmholtz Zentrum München Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 64. Kaneka Eurogentec Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 65. Beijing Abace Biology Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 66. Beijing Sino Biological Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 67. Nanjing GenScript Biotechnology Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 68. Shanghai Sangon Biotech Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 69. Nanjing Zoonbio Biotechnology Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 70. Suzhou Synbio Technologies Revenue Growth Rate in Antibody Development and Production Service Business (2020-2025)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
